GASTROINTESTINAL TUMORS
Clinical trials for GASTROINTESTINAL TUMORS explained in plain language.
Never miss a new study
Get alerted when new GASTROINTESTINAL TUMORS trials appear
Sign up with your email to follow new studies for GASTROINTESTINAL TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for GIST: experimental combo targets hard-to-treat tumors
Disease control Recruiting nowThis study tests whether adding an experimental drug (KQB198) to the standard cancer pill imatinib can shrink or control advanced gastrointestinal stromal tumors (GIST). About 46 adults with a specific gene mutation (KIT or PDGFRA) will receive the combination. The goal is to see…
Matched conditions: GASTROINTESTINAL TUMORS
Phase: PHASE2 • Sponsor: Kumquat Biosciences Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New drug BL-M24D1 enters early human testing for Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase study tests a new drug called BL-M24D1 in 33 people with advanced gastrointestinal or other solid tumors that have spread. The main goals are to check safety, find the right dose, and get a first look at whether the drug shrinks tumors. Participants receive the d…
Matched conditions: GASTROINTESTINAL TUMORS
Phase: PHASE1 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Radioactive drug targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis early-stage trial tests a new radioactive drug, lutetium BL-ARC001, in 22 people with advanced gastrointestinal or other solid tumors that have spread. The main goals are to check safety, find the right dose, and see early signs of tumor shrinkage. Participants receive the d…
Matched conditions: GASTROINTESTINAL TUMORS
Phase: PHASE1 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC